Supplemental
1 Values are odds ratios modeling the probability of high sCD14 levels i.e., ≥ median (1,915 ng/mL). sCD14 concentrations were LN-transformed prior to analyses. 2 Dietary patterns were adjusted for energy intake using the residual method prior to analyses. All analyses were adjusted for age at blood draw, sex, physical activity, smoking status, case-control status, regular use of aspirin, acetaminophen, other non-steroidal anti-inflammatory drugs (NSAID), cholesterol lowering drugs, body mass index, and a chronic disease comorbidity score. Chronic diseases/conditions included in the score were hypercholesterolemia, cancer, diabetes, high blood pressure, heart disease, rheumatoid/other arthritis, Crohn's disease/ulcerative colitis; 3 The p-value for trend was the p-value of the dietary pattern as a continuous variable adjusted for all covariates listed in footnote #2;
Supplemental Variance explained by each factor: GP130/TNFR2 = 1.526, TNFR2/IL2R=1.000 and CD14 dominant=0.8690, total variance explained=3.3951; CRP=C-reactive protein, IL-8=interleukin-8, sCD14=soluble CD14, sIL-2Rα=soluble interleukin-2 receptor-α, sIL-6Rα=soluble interleukin-6 receptor, sGP130=soluble gp130, sTNFR2=soluble tumor necrosis factor alpha receptor 2. Biomarkers shown in bold indicate highest loading factors that gave rise to factor pattern names. 2 )]. The sCD14-dominant biomarker pattern score was derived using factor analysis and included the following inflammation and immune response markers: sCD14, CRP, sTNFR2, IL-8, sGP130, sIL-2Rα, sIL-6Rα. Bars show odds ratios, whiskers indicate 95% CI, from logistic regression analyses comparing higher categories to the lowest category as reference (ref, OR=1) . All analyses were adjusted for age at blood draw, sex, physical activity, smoking status, lymphoma case-control status, regular use of aspirin, acetaminophen, other non-steroidal anti-inflammatory drugs (NSAID), cholesterol-lowering drugs, and an inflammation-related chronic disease comorbidity score as described in the methods section. 
